Delayed  ||| S:0 E:8 ||| VBN
quadriceps  ||| S:8 E:19 ||| JJ
weakness  ||| S:19 E:28 ||| NN
after  ||| S:28 E:34 ||| IN
continuous  ||| S:34 E:45 ||| JJ
adductor  ||| S:45 E:54 ||| JJ
canal  ||| S:54 E:60 ||| NN
block  ||| S:60 E:66 ||| NN
for  ||| S:66 E:70 ||| IN
total  ||| S:70 E:76 ||| JJ
knee  ||| S:76 E:81 ||| NN
arthroplasty ||| S:81 E:93 ||| NNS
:  ||| S:93 E:95 ||| :
a  ||| S:95 E:97 ||| DT
case  ||| S:97 E:102 ||| NN
report  ||| S:102 E:109 ||| NN
Adductor  ||| S:109 E:118 ||| NNP
canal  ||| S:118 E:124 ||| NN
catheters  ||| S:124 E:134 ||| NNS
have  ||| S:134 E:139 ||| VBP
been  ||| S:139 E:144 ||| VBN
shown  ||| S:144 E:150 ||| VBN
to  ||| S:150 E:153 ||| TO
improve  ||| S:153 E:161 ||| VB
analgesia  ||| S:161 E:171 ||| VBN
while  ||| S:171 E:177 ||| IN
maintaining  ||| S:177 E:189 ||| VBG
quadriceps  ||| S:189 E:200 ||| JJ
strength  ||| S:200 E:209 ||| NN
after  ||| S:209 E:215 ||| IN
total  ||| S:215 E:221 ||| JJ
knee  ||| S:221 E:226 ||| NN
arthroplasty ||| S:226 E:238 ||| NN
.  ||| S:238 E:240 ||| .
We  ||| S:240 E:243 ||| PRP
describe  ||| S:243 E:252 ||| VBP
a  ||| S:252 E:254 ||| DT
patient  ||| S:254 E:262 ||| NN
who  ||| S:262 E:266 ||| WP
underwent  ||| S:266 E:276 ||| VBD
total  ||| S:276 E:282 ||| JJ
knee  ||| S:282 E:287 ||| NN
arthroplasty  ||| S:287 E:300 ||| NNS
that  ||| S:300 E:305 ||| WDT
likely  ||| S:305 E:312 ||| RB
had  ||| S:312 E:316 ||| VBD
delayed  ||| S:316 E:324 ||| VBN
quadriceps  ||| S:324 E:335 ||| JJ
weakness  ||| S:335 E:344 ||| NN
as  ||| S:344 E:347 ||| IN
a  ||| S:347 E:349 ||| DT
result  ||| S:349 E:356 ||| NN
of  ||| S:356 E:359 ||| IN
a  ||| S:359 E:361 ||| DT
standard  ||| S:361 E:370 ||| JJ
continuous  ||| S:370 E:381 ||| JJ
0.2 ||| S:381 E:384 ||| CD
%  ||| S:384 E:386 ||| NN
ropivacaine  ||| S:386 E:398 ||| NN
infusion  ||| S:398 E:407 ||| NN
at  ||| S:407 E:410 ||| IN
8  ||| S:410 E:412 ||| CD
ml ||| S:412 E:414 ||| CD
/ ||| S:414 E:415 ||| CD
h  ||| S:415 E:417 ||| NN
within  ||| S:417 E:424 ||| IN
the  ||| S:424 E:428 ||| DT
adductor  ||| S:428 E:437 ||| JJ
canal ||| S:437 E:442 ||| NN
.  ||| S:442 E:444 ||| .
On  ||| S:444 E:447 ||| IN
the  ||| S:447 E:451 ||| DT
day  ||| S:451 E:455 ||| NN
of  ||| S:455 E:458 ||| IN
surgery ||| S:458 E:465 ||| NN
,  ||| S:465 E:467 ||| ,
the  ||| S:467 E:471 ||| DT
patient  ||| S:471 E:479 ||| NN
was  ||| S:479 E:483 ||| VBD
able  ||| S:483 E:488 ||| JJ
to  ||| S:488 E:491 ||| TO
stand  ||| S:491 E:497 ||| VB
and  ||| S:497 E:501 ||| CC
ambulate  ||| S:501 E:510 ||| NN
with  ||| S:510 E:515 ||| IN
minimal  ||| S:515 E:523 ||| JJ
assistance ||| S:523 E:533 ||| NN
.  ||| S:533 E:535 ||| .
On  ||| S:535 E:538 ||| IN
the  ||| S:538 E:542 ||| DT
first  ||| S:542 E:548 ||| JJ
post-operative  ||| S:548 E:563 ||| JJ
day  ||| S:563 E:567 ||| NN
after  ||| S:567 E:573 ||| IN
surgery ||| S:573 E:580 ||| NN
,  ||| S:580 E:582 ||| ,
approximately  ||| S:582 E:596 ||| RB
20  ||| S:596 E:599 ||| CD
h  ||| S:599 E:601 ||| NN
after  ||| S:601 E:607 ||| IN
starting  ||| S:607 E:616 ||| VBG
the  ||| S:616 E:620 ||| DT
ropivacaine  ||| S:620 E:632 ||| JJ
infusion ||| S:632 E:640 ||| NN
,  ||| S:640 E:642 ||| ,
profound  ||| S:642 E:651 ||| JJ
weakness  ||| S:651 E:660 ||| NN
of  ||| S:660 E:663 ||| IN
the  ||| S:663 E:667 ||| DT
quadriceps  ||| S:667 E:678 ||| NN
was  ||| S:678 E:682 ||| VBD
noted  ||| S:682 E:688 ||| VBN
with  ||| S:688 E:693 ||| IN
no  ||| S:693 E:696 ||| DT
ability  ||| S:696 E:704 ||| NN
to  ||| S:704 E:707 ||| TO
stand ||| S:707 E:712 ||| VB
.  ||| S:712 E:714 ||| .
Contrast  ||| S:714 E:723 ||| NN
subsequently  ||| S:723 E:736 ||| RB
injected  ||| S:736 E:745 ||| VBN
through  ||| S:745 E:753 ||| IN
the  ||| S:753 E:757 ||| DT
adductor  ||| S:757 E:766 ||| JJ
canal  ||| S:766 E:772 ||| NN
catheter  ||| S:772 E:781 ||| NN
under  ||| S:781 E:787 ||| IN
fluoroscopy  ||| S:787 E:799 ||| JJ
revealed  ||| S:799 E:808 ||| NNS
proximal  ||| S:808 E:817 ||| VBP
spread  ||| S:817 E:824 ||| VBN
approaching  ||| S:824 E:836 ||| VBG
the  ||| S:836 E:840 ||| DT
common  ||| S:840 E:847 ||| JJ
femoral  ||| S:847 E:855 ||| JJ
nerve  ||| S:855 E:861 ||| NN
with  ||| S:861 E:866 ||| IN
as  ||| S:866 E:869 ||| IN
little  ||| S:869 E:876 ||| JJ
as  ||| S:876 E:879 ||| IN
2  ||| S:879 E:881 ||| CD
ml  ||| S:881 E:884 ||| NN
of  ||| S:884 E:887 ||| IN
volume ||| S:887 E:893 ||| NN
.  ||| S:893 E:895 ||| .
This  ||| S:895 E:900 ||| DT
rare  ||| S:900 E:905 ||| JJ
case  ||| S:905 E:910 ||| NN
of  ||| S:910 E:913 ||| IN
profound  ||| S:913 E:922 ||| JJ
quadriceps  ||| S:922 E:933 ||| JJ
weakness  ||| S:933 E:942 ||| NN
after  ||| S:942 E:948 ||| IN
a  ||| S:948 E:950 ||| DT
continuous  ||| S:950 E:961 ||| JJ
adductor  ||| S:961 E:970 ||| JJ
canal  ||| S:970 E:976 ||| NN
block  ||| S:976 E:982 ||| NN
reveals  ||| S:982 E:990 ||| VBZ
that  ||| S:990 E:995 ||| DT
local  ||| S:995 E:1001 ||| JJ
anaesthetic  ||| S:1001 E:1013 ||| NN
at  ||| S:1013 E:1016 ||| IN
the  ||| S:1016 E:1020 ||| DT
adductor  ||| S:1020 E:1029 ||| JJ
canal  ||| S:1029 E:1035 ||| NN
can  ||| S:1035 E:1039 ||| MD
spread  ||| S:1039 E:1046 ||| VB
in  ||| S:1046 E:1049 ||| IN
a  ||| S:1049 E:1051 ||| DT
retrograde  ||| S:1051 E:1062 ||| JJ
fashion  ||| S:1062 E:1070 ||| NN
towards  ||| S:1070 E:1078 ||| IN
the  ||| S:1078 E:1082 ||| DT
common  ||| S:1082 E:1089 ||| JJ
femoral  ||| S:1089 E:1097 ||| JJ
nerve ||| S:1097 E:1102 ||| NN
,  ||| S:1102 E:1104 ||| ,
potentially  ||| S:1104 E:1116 ||| RB
resulting  ||| S:1116 E:1126 ||| VBG
in  ||| S:1126 E:1129 ||| IN
quadriceps  ||| S:1129 E:1140 ||| JJ
weakness ||| S:1140 E:1148 ||| NN
.  ||| S:1148 E:1150 ||| .
